Last reviewed · How we verify
NCT04750096: ERASE
Esophagectomy Enhanced Recovery After Surgery Protocol
trial in Esophagectomy in 100 participants. Status unknown.
1 September 2022
Quick facts
| Lead sponsor | Raquel Ferrandis Comes |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 100 |
| Start date | 1 September 2020 |
| Primary completion | 1 September 2022 |
| Estimated completion | 31 December 2022 |
| Sites | 1 location across Spain |
Conditions studied
- Esophagectomy — all drugs for Esophagectomy →
Sponsor
Raquel Ferrandis Comes
Who can join
Adults 18 to 90, any sex, with Esophagectomy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Despite the important advances in anaesthesia and the implementation of perioperative care, pulmonary complications in esophagectomy reach figures of between 20 and 35%, and these complications are also closely associated with the mortality rate. Factors that have been associated with the development of respiratory failure in the literature include among others the presence of previous respiratory pathology, history of smoking, malnutrition and rescue surgery. With the aim of improving morbimortality in patients undergoing esophagectomy, a multidisciplinary protocol based on the best scientific evidence at the present time has been implemented, with actions covering both the preoperative and postoperative areas. Based on this point, a prospective study has been designed that allows us to compare the incidence of respiratory failure before and after the implementation of the protocol.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04750096
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Esophagectomy
Currently open trials in the same condition.
- NCT06911658 — Infectious Complications After Esophagectomy · recruiting
- NCT06271707 — Stellate Ganglion Block · Phase 4 · recruiting
- NCT06721520 — Effectiveness of Methods for Pyloric Drainage in esophagecTomY: Botox vs. Pyloromyotomy · Phase 2, PHASE3 · recruiting
- NCT05950438 — Investigating Outcomes of Elective Robotic Transhiatal Esophagectomy · recruiting
- NCT04654975 — Metachronic Brain Metastases After Esophagectomy for Esophageal Cancer (METABREC) · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04750096 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Raquel Ferrandis Comes
- Last refreshed: 11 February 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04750096.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing